Urotensin-II: a novel systemic hypertensive factor in the cat

Author： Behm David   Doe Christopher   Johns Douglas   Maniscalco Kristeen   Stankus Gerald   Wibberley Alexandra   Willette Robert   Douglas Stephen  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.369, Iss.3, 2004-03, pp. : 274-280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Urotensin-II Receptor Antagonists

By  

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 267-275

Bentham Science Publishers

Access to resources Recommend Favorite

Urotensin-II and the cardiovascular system – the importance of developing modulators

By Doggrell Sheila A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 479-487

Informa Healthcare

Access to resources Recommend Favorite

Non-peptidic urotensin-II receptor modulators

By Jin Jian   Douglas Stephen A  

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 4, 2006-04 ,pp. : 467-479

Informa Healthcare

Access to resources Recommend Favorite

Recent Structure-Activity Studies of the Peptide Hormone Urotensin-II, a Potent Vasoconstrictor

By  

Current Medicinal Chemistry, Vol. 11, Iss. 8, 2004-04 ,pp. : 969-979

Bentham Science Publishers

Access to resources Recommend Favorite

Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats

By Gendron Gabrielle   Simard Bryan   Gobeil   Jr. Fernand   Sirois Pierre   D'Orléans-Juste Pedro   Regoli Domenico  

Canadian Journal of Physiology and Pharmacology, Vol. 82, Iss. 1, 2004-01 ,pp. : 16-21

NRC Research Press

Access to resources Recommend Favorite